These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15720806)
21. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798 [TBL] [Abstract][Full Text] [Related]
22. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype. Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496 [TBL] [Abstract][Full Text] [Related]
23. Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa. Sundlisaeter E; Røsland GV; Hertel JK; Sakariassen PØ; Almås B; Dicko A; Søndenaa K APMIS; 2009 Mar; 117(3):212-21. PubMed ID: 19245594 [TBL] [Abstract][Full Text] [Related]
24. Altered expression of the KLF4 in colorectal cancers. Choi BJ; Cho YG; Song JW; Kim CJ; Kim SY; Nam SW; Yoo NJ; Lee JY; Park WS Pathol Res Pract; 2006; 202(8):585-9. PubMed ID: 16814484 [TBL] [Abstract][Full Text] [Related]
25. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis. Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550 [TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709 [TBL] [Abstract][Full Text] [Related]
27. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812 [TBL] [Abstract][Full Text] [Related]
28. Impact of PINCH expression on survival in colorectal cancer patients. Lööf J; Rosell J; Bratthäll C; Doré S; Starkhammar H; Zhang H; Sun XF BMC Cancer; 2011 Mar; 11():103. PubMed ID: 21426571 [TBL] [Abstract][Full Text] [Related]
29. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer]. Fan YZ; Li XP; Liu WF; Li GM Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348 [TBL] [Abstract][Full Text] [Related]
30. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
31. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Koukourakis MI; Giatromanolaki A; Harris AL; Sivridis E Cancer Res; 2006 Jan; 66(2):632-7. PubMed ID: 16423989 [TBL] [Abstract][Full Text] [Related]
32. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL; J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877 [TBL] [Abstract][Full Text] [Related]
37. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863 [TBL] [Abstract][Full Text] [Related]
39. Galectin-3 expression is a potent prognostic marker in colorectal cancer. Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575 [TBL] [Abstract][Full Text] [Related]
40. Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study. Hasebe T; Konishi M; Iwasaki M; Endoh Y; Nakagohri T; Takahashi S; Kinoshita T; Ochiai A Hum Pathol; 2005 Jun; 36(6):655-64. PubMed ID: 16021572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]